�?ステップ２：投与溶媒の組成を入力してください。（ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください） Risdiplam (Evrysdi®) is the primary oral drug developed to treat spinal muscular atrophy (SMA) and is particularly accredited in several countries around the world. It's accepted for the cure of SMA in patients aged ≥ two months within the USA ... https://jamest630fjn2.salesmanwiki.com/user